Study: Throat spray, anti-malaria drug reduce Covid risk

Simple item page
dc.contributor.authorChong, Clara
dc.date.accessioned2021-04-27T02:13:32Z
dc.date.available2021-04-27T02:13:32Z
dc.date.issued2021-04-26
dc.descriptionpage 3en_US
dc.identifier.urihttp://hdl.handle.net/123456789/42149
dc.language.isoenen_US
dc.publisherThe New Paperen_US
dc.subjectVirusen_US
dc.subjectMedical awarenessen_US
dc.titleStudy: Throat spray, anti-malaria drug reduce Covid risken_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
April 26, 2021 pg 3.pdf
Size:
112 KB
Format:
Adobe Portable Document Format
Description:
Study: Throat spray, anti-malaria drug reduce Covid risk
Download

License bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Newspaper Clippings